Targeting PI3K mTOR pathway in hepatocellular carcinoma Hepatocellular carcinoma (HCC) mammalian target of rapamycin (mTOR) phospho inositide 3 kinase (PI3K). Hepatozelluläres Karzinom Säuger Zielgen für Rapamycin Phosphoinositol 3 Kinase